All Stories

  1. Helicobacter pylori infection in the stomach induces neuroinflammation: the potential roles of bacterial outer membrane vesicles in an animal model of Alzheimer’s disease
  2. Scientific evaluation of alleged findings in HPV vaccines: Molecular mimicry and mouse models of vaccine‐induced disease
  3. Bacterial and fungal isolation from face masks under the COVID-19 pandemic
  4. Corrigendum: Curcumin β-D-Glucuronide Modulates an Autoimmune Model of Multiple Sclerosis with Altered Gut Microbiota in the Ileum and Feces
  5. Regular Exercise Training Enhances Spatial Memory and Regulates Glucocorticoid System in Experimental Autoimmune Encephalomyelitis
  6. Curdlan, a Microbial β-Glucan, Has Contrasting Effects on Autoimmune and Viral Models of Multiple Sclerosis
  7. Curcumin β-D-Glucuronide Modulates an Autoimmune Model of Multiple Sclerosis with Altered Gut Microbiota in the Ileum and Feces
  8. Evaluation of Five International HBV Treatment Guidelines: Recommendation for Resource-Limited Developing Countries Based on the National Study in Nepal
  9. Galectin-3 as a Therapeutic Target for NSAID-Induced Intestinal Ulcers
  10. Scientific Evaluation of the Court Evidence Submitted to the 2019 Human Papillomavirus Vaccine Libel Case and Its Decision in Japan
  11. Bioinformatics Analysis of Gut Microbiota and CNS Transcriptome in Virus-Induced Acute Myelitis and Chronic Inflammatory Demyelination; Potential Association of Distinct Bacteria With CNS IgA Upregulation
  12. Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis
  13. Bioinformatics Analyses Determined the Distinct CNS and Peripheral Surrogate Biomarker Candidates Between Two Mouse Models for Progressive Multiple Sclerosis
  14. Theiler's Virus-Mediated Immunopathology in the CNS and Heart: Roles of Organ-Specific Cytokine and Lymphatic Responses
  15. IL-1β reduces cardiac lymphatic muscle contraction via COX-2 and PGE2 induction: Potential role in myocarditis
  16. Forensic luminol reaction for detecting fecal occult blood in experimental mice
  17. Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130
  18. Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease
  19. Murine γ-Herpesvirus 68 Induces Severe Lung Inflammation in IL-27–Deficient Mice with Liver Dysfunction Preventable by Oral Neomycin
  20. Immunoregulation of Theiler’s virus-induced demyelinating disease by glatiramer acetate without suppression of antiviral immune responses
  21. Metallothionein I as a direct link between therapeutic hematopoietic stem/progenitor cells and cerebral protection in stroke
  22. CCL28-Deficient Mice Have Reduced IgA Antibody–Secreting Cells and an Altered Microbiota in the Colon
  23. Bioinformatics analyses determined the CNS and peripheral lymphoid surrogate biomarker candidates between two distinct EAE models for progressive multiple sclerosis
  24. Viral infection activates myelin-specific T cells, triggering MS-like CNS inflammatory demyelination
  25. T-bet, but not Gata3, overexpression is detrimental in a neurotropic viral infection
  26. Lymphatic system and gut microbiota affect immunopathology of neuroinflammatory diseases, including multiple sclerosis, neuromyelitis optica and Alzheimer's disease
  27. Helicobacter pylori and gut microbiota in multiple sclerosis versus Alzheimer's disease: 10 pitfalls of microbiome studies
  28. From trash to treasure: The untapped potential of endothelial microparticles in neurovascular diseases
  29. IL-35 Suppresses Lipopolysaccharide-Induced Airway Eosinophilia in EBI3-Deficient Mice
  30. One single virus induces three different diseases
  31. A Critical Role for Monocytes/Macrophages During Intestinal Inflammation-associated Lymphangiogenesis
  32. Role of CD4+ T Cells in the Pathophysiology of Multiple Sclerosis
  33. “Microglial nodules” and “newly forming lesions” may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model
  34. Blood circulating microparticle species in relapsing–remitting and secondary progressive multiple sclerosis. A case–control, cross sectional study with conventional MRI and advanced iron content imaging outcomes
  35. IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2
  36. Animal models of Multiple Sclerosis
  37. Anti-Yo Antibody Uptake and Interaction with Its Intracellular Target Antigen Causes Purkinje Cell Death in Rat Cerebellar Slice Cultures: A Possible Mechanism for Paraneoplastic Cerebellar Degeneration in Humans with Gynecological or Breast Cancers
  38. Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis
  39. Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis
  40. Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain
  41. Distinct kinetics of viral replication, T cell infiltration, and fibrosis in three phases of myocarditis following Theiler’s virus infection
  42. RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis
  43. Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures
  44. Bioinformatics Multivariate Analysis Determined a Set of Phase-Specific Biomarker Candidates in a Novel Mouse Model for Viral Myocarditis
  45. COMPUTATIONAL MULTIVARIATE ANALYSES FOR PHASE-SPECIFIC BIOMARKER IDENTIFICATION IN NOVEL IN VIVO AND IN VITRO VIRAL MYOCARDITIS MODELS INDUCED BY CARDIOVIRUS
  46. Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis
  47. Regulation of an Autoimmune Model for Multiple Sclerosis in Th2-Biased GATA3 Transgenic Mice
  48. Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis
  49. Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature
  50. Venous endothelial injury in central nervous system diseases
  51. Therapeutic Evaluation of Ex Vivo-Generated Versus Natural Regulatory T-cells in a Mouse Model of Chronic Gut Inflammation
  52. Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?
  53. Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis
  54. Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis
  55. Immunization with structural and non-structural proteins of Theiler’s murine encephalomyelitis virus alters demyelinating disease
  56. Antiviral CD8+ T cells cause an experimental autoimmune encephalomyelitis-like disease in naive mice
  57. Heterogeneity versus homogeneity of multiple sclerosis
  58. Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration
  59. Animal Models of Multiple Sclerosis
  60. Purkinje Cell Death After Uptake of Anti-Yo Antibodies in Cerebellar Slice Cultures
  61. Studies in the Modulation of Experimental Autoimmune Encephalomyelitis
  62. Neuropathogenesis of Theiler’s Murine Encephalomyelitis Virus Infection, An Animal Model for Multiple Sclerosis
  63. The Importance of NAD in Multiple Sclerosis
  64. Contrasting roles for Vα14 + natural killer T cells in a viral model for multiple sclerosis
  65. Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding
  66. Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis
  67. Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection
  68. Regulatory Role of CD1d in Neurotropic Virus Infection
  69. Role of B:T cell ratio in suppression of clinical signs: A model for silent MS
  70. Role of CD5+B-1 cells in EAE pathogenesis
  71. Cross-reactive myelin antibody induces renal pathology
  72. Targeting Inflammatory Demyelinating Lesions to Sites of Wallerian Degeneration
  73. TGF-β1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus
  74. Sequential polymicrobial infections lead to CNS inflammatory disease: Possible involvement of bystander activation in heterologous immunity
  75. Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis
  76. Contrasting Roles for Axonal Degeneration in an Autoimmune versus Viral Model of Multiple Sclerosis
  77. Modulation of Experimental Autoimmune Encephalomyelitis by VLA-2 Blockade
  78. Infectious RNA Isolated from the Spinal Cords of Mice Chronically Infected with Theiler's Murine Encephalomyelitis Virus
  79. Autologous hematopoietic stem cell transplantation: a cure for multiple sclerosis?
  80. The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: Implications for multiple sclerosis
  81. Antibody Association with a Novel Model for Primary Progressive Multiple Sclerosis: Induction of Relapsing-Remitting and Progressive Forms of EAE in H2S Mouse Strains
  82. Monoclonal MOG-reactive autoantibody from progressive EAE has the characteristics of a natural antibody
  83. IFN-γ production and astrocyte recognition by autoreactive T cells induced by Theiler's virus infection: Role of viral strains and capsid proteins
  84. Multiple sclerosis and virus induced immune responses: Autoimmunity can be primed by molecular mimicry and augmented by bystander activation
  85. Central Nervous System Pathology Caused by Autoreactive CD8+ T-Cell Clones following Virus Infection
  86. Massive Apoptosis in Lymphoid Organs in Animal Models for Primary and Secondary Progressive Multiple Sclerosis
  87. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation
  88. Distinct roles for IP-10/C XC L10 in three animal models, Theiler’s virus infection, EA E, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10
  89. Axonal Injury Heralds Virus-Induced Demyelination
  90. Modulation of Immune System Function by Measles Virus Infection. II. Infection of B Cells Leads to the Production of a Soluble Factor That Arrests Uninfected B Cells in G 0 /G 1
  91. Induction of Autoreactive CD8+ Cytotoxic T Cells during Theiler's Murine Encephalomyelitis Virus Infection: Implications for Autoimmunity
  92. Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination
  93. Altered Cell Growth and Morphology in a BHK-21 Cell Mutant That Lacks a Receptor for Theiler's Murine Encephalomyelitis Virus
  94. Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: A mechanism for the failure of persistence by the mutant virus
  95. Prolonged Gray Matter Disease without Demyelination Caused by Theiler's Murine Encephalomyelitis Virus with a Mutation in VP2 Puff B
  96. Viruses can silently prime for and trigger central nervous system autoimmune disease
  97. Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus
  98. Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler’s virus infections
  99. Exacerbation of Viral and Autoimmune Animal Models for Multiple Sclerosis by Bacterial DNA
  100. Lipopeptide particles as the immunologically active component of CTL inducing vaccines
  101. Replacement of Loop II of VP1 of the DA Strain with Loop II of the GDVII Strain of Theiler’s Murine Encephalomyelitis Virus Alters Neurovirulence, Viral Persistence, and Demyelination
  102. Enhancement of Experimental Allergic Encephalomyelitis (EAE) by DNA Immunization with Myelin Proteolipid Protein (PLP) Plasmid DNA
  103. Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection
  104. Hydrocephalus in Mice Infected with a Theilerʼs Murine Encephalomyelitis Virus Variant
  105. Apoptosis in Acute and Chronic Central Nervous System Disease Induced by Theiler's Murine Encephalomyelitis Virus
  106. Two Models for Multiple Sclerosis: Experimental Allergic Encephalomyelitis and Theilerʼs Murine Encephalomyelitis Virus
  107. A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus
  108. Suppression of acute active EAE with a derivative of mycophenolic acid
  109. Idiopathic AA amyloidosis manifested by autonomic neuropathy, vestibulocochleopathy, and lattice corneal dystrophy.
  110. Acute Simultaneous Bilateral Vestibulocochlear Impairment in Neuro-Behçetls Disease: A Case Report
  111. Phenotypes of mononuclear cell infiltrates in human central nervous system
  112. ANTI-VERY LATE ANTIGEN-4 ANTIBODY SUPPRESSES ACUTE ACTIVE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN LEWIS RATS
  113. TMEV and Neuroantigens: Myelin Genes and Proteins, Molecular Mimicry, Epitope Spreading, and Autoantibody-Mediated Remyelination
  114. Central Nervous System Degeneration Caused by Autoimmune Cytotoxic CD8+ T Cell Clones and Hybridomas